Skip to main content

Table 5 Participant practices when diagnosing and managing patients with AF

From: Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights

Practice items

Frequency

Percentage %

Have you ever made differential diagnosis according to the duration of the onset of atrial fibrillation

Never

189

38.0

Sometimes

162

32.6

Often

124

24.9

Always

22

4.4

Have you ever made differential diagnosis between valvular AF and non-valvular AF in AF patients when you deal with AF

Never

71

14.3

Sometimes

112

22.5

Often

129

26.0

Always

185

37.2

Do you use stroke risk score tools to assess stroke risk in AF patients?

Never

77

15.5

Sometimes

104

20.9

Often

160

32.2

Always

156

31.4

Do you use bleeding risk score tools to assess bleeding risk in AF patients

Never

78

15.7

Sometimes

117

23.5

Often

161

32.4

Always

141

28.4

For AF patients treated with warfarin, the INR is maintained at 1.1–2.0. Would you increase the warfarin dose for this p

Never

62

12.5

Sometimes

163

32.8

Often

168

33.8

Always

104

20.9

For AF patients treated with warfarin, the INR is maintained at 3.5–5.5. Would you decrease the warfarin dose for this p

Never

16

3.2

Sometimes

120

24.1

Often

177

35.6

Always

184

37.0

A 75-year-old male NVAF patient, with hypertension and no history of diabetes and cardiovascular disease, would you give this patient warfarin for anticoagulant treatment?

Never

110

22.1

Sometimes

181

36.4

Often

154

31.0

Always

52

10.5

A 75-year-old female NVAF patient, with history of hypertension, congestive heart failure and TIA 3 years ago. Ultrasound indicated aortic atherosclerosis and atrial enlargement. Would you give this patient oral anticoagulant therapy

Never

36

7.2

Sometimes

114

22.9

Often

162

32.6

Always

185

37.2

The AF patient in E8 item had gastrointestinal bleeding 3 months ago and has stopped bleeding for 1 week. Would you give this patient oral anticoagulant therapy?

Never

163

32.8

Sometimes

168

33.8

Often

140

28.2

Always

26

5.2

The AF patient in E8 item had nosebleeds once and gum bleeds occasionally when brushing his teeth. Would you give this p

Never

193

38.8

Sometimes

153

30.8

Often

120

24.1

Always

31

6.2

The AF patient in E8 item has taken coronary stent implantation for 1 month, would you give the patient dual antiplatelet and warfarin therapy

Never

86

17.3

Sometimes

185

37.2

Often

162

32.6

Always

64

12.9

The AF patient in E8 item with ACS has taken coronary stent implantation and has been stable for 1 year. Would you give

Never

55

11.1

Sometimes

167

33.6

Often

202

40.6

Always

73

14.7

A 68-year-old hypertensive female patient with recurrent episodes of paroxysmal atrial fibrillation and without previous

Never

34

6.8

Sometimes

168

33.8

Often

206

41.4

Always

89

17.9

Have you often told AF patients who use warfarin therapy about the food and drugs that interacts with warfarin?

Never

81

16.3

Sometimes

128

25.8

Often

143

28.8

Always

145

29.2

Have you ever actively communicated with AF patients with about increasing the risk of AF-related stroke and anticoagulation

Never

89

17.9

Sometimes

129

26.0

Often

158

31.8

Always

121

24.3

Have you ever used different methods, such as pamphlets, health lectures and education, to educate AF patients about the

Never

236

47.5

Sometimes

129

26.0

Often

83

16.7

Always

49

9.9

Have you ever attended relevant training or learned lectures about atrial fibrillation diseases and anticoagulation

Never

234

47.1

Sometimes

112

22.5

Often

89

17.9

Always

62

12.5

Will you attend the training about AF disease and anticoagulation therapy?

Never

31

6.2

Sometimes

85

17.1

Often

246

49.5

Always

135

27.2